Master ReVasca Monograph 6.2.24 - Paper - Page 11
REVASCA™ PHYSICIAN MONOGRAPH
— References —
1. Van Teffelen JW, et al. Endothelial glyclocalyx: Sweet shield of blood vessels. Trends Cardiovasc Med.
2007;17:101-05.
2. Dogne S, Flamion B. Endothelial glyclcalyx impairment in disease: focus on hyaluronan shedding. Am J
Pathol. 2020;190(4):768-80.
3. Butler MJ, et al. The Pathological Relevance of Increased Endothelial Glycocalyx Permeability. Am. J. Pathol.
2020;190;742–751.
4. Jin J, et al. The structure and function of the glycocalyx and its connection with blood-brain barrier. Front Cell
Neurosci. 2021;15:739699.
5. Zhao F, et al. Endothelial glycocalyx as an important factor in composition of blood-brain barrier. CNS Neuros
ci Ther. 2021;27(1):26-35.
6. Mockl L. The emerging role of the mammalian glycocalyx in functional membrane organization and immune
system regulation. Front Cell Dev Biol. 2020;8:253.
7. Iba T, et al. Derangement of endothelial glycocalyx in sepsis. J Thormb Haemost. 2019;17:283-94.
8. Schiffrin EL, et al. Chronic kidney disease: Effects on the cardiovascular system. Circulation 2007, 116, 85–97.
9. Regier M, et al. A Dietary Supplement Containing Fucoidan Preserves Endothelial Glycocalyx through
ERK/MAPK Signaling and Protects against Damage Induced by CKD Serum. Int J Mol Sci. 2022;23(24):15520.
10. Targosz-Korecka M, et al. Endothelial glycocalyx shields the interaction of SARS-CoV-2 spike protein with
ACE2 receptors. Sci Reports. 2021;11:12157.
11. Yuan L, et al. Heparan sulfate mimetic fucoidan restores the endothelial glycocalyx and protects against
dysfunction induced by serum of COVID-19 patients in the intensive care unit. ERJ Open Res.
2022;8(2):00652-2021.
12. Machin DR, et al. Glycocalyx-targeted therapy ameliorates age-related arterial dysfunction. Geroscience.
2023;[ahead of print].
13. Chappell D, et al. Hydrocortisone preserves the vascular barrier by protecting the endothelial glycocalyx.
Anesthesiology. 2007;107(5):776–84.
14. Machin DR, et al. Glycocalyx-targeted therapy ameliorates age-related arterial dysfunction. Geroscience.
2023;[ahead of print].
15. Regier M, et al. A Dietary Supplement Containing Fucoidan Preserves Endothelial Glycocalyx through
ERK/MAPK Signaling and Protects against Damage Induced by CKD Serum. Int J Mol Sci. 2022;23(24):15520.
16. Bai Y, et al. A new biomaterial derived from Aloe vera – acemannan from basic studies to clinical application.
Pharmaceutics. 2023;15(7):1913.
17. Besco R, et al. The effects of nitric oxide related supplements on human performance. Sports Med.
2012;42:99-117.